Browse every story filed under this topic, curated from trusted publishers around the world.
A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and …
Read full story →
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression …
Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as breakthroughs.
UnitedHealth Group is moving up its share repurchase timeline, announcing plans to deploy at least $2 billion in buybacks by …
Former India captain Kris Srikkanth has urged selectors to fast-track 15-year-old Vaibhav Sooryavanshi into the national team, comparing him to …
President Trump signed an executive order Saturday for a speedy review of psychedelic drugs, including ibogaine.
A new four-week training program from Meta aims to address the shortage of fiber technicians as AI companies sprint to …
You've seen all articles for #fast-tracks.
Check back
soon
for new stories.